Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-175,000
Closed -$7.01M 6149
2026
Q1
$7.01M Buy
+175,000
New +$8.28M ﹤0.01% 1710
2023
Q3
Sell
-311,208
Closed -$14.8M 5770
2023
Q2
$14.8M Buy
+311,208
New +$15M 0.01% 956
2020
Q4
Sell
-94,306
Closed -$5.23M 7576
2020
Q3
$5.23M Hold
94,306
﹤0.01% 1852
2020
Q2
$4.28M Buy
94,306
+61,393
+187% +$2.75M ﹤0.01% 2007
2020
Q1
$1.45M Hold
32,913
﹤0.01% 2805
2019
Q4
$1.18M Buy
+32,913
New +$1.22M ﹤0.01% 3591

Other funds holding QGEN

Citigroup's QGEN Position: Q2 2026 in Review

Citigroup reduced its Qiagen (QGEN) stake by 46% in Q2 2026, selling an estimated $23.4M and leaving 754,880 shares worth $29.5M. The position accounts for 0.01% of the portfolio, ranked #965.

Citigroup first reported a position in QGEN in Q1 2017 and has held it in 38 quarters since. The position peaked at $437M in Q2 2020. 337 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Citigroup held 754,880 shares of Qiagen worth $29.5M as of Q2 2026.
  • Citigroup sold 630,231 Qiagen shares in Q2 2026, an estimated $23.4M.
  • Qiagen made up 0.01% of Citigroup's portfolio in Q2 2026, its #965 holding.
  • Citigroup first reported a position in Qiagen in Q1 2017 and has held it in 38 quarters since.
  • Citigroup's Qiagen position peaked at $437M in Q2 2020.
  • 337 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.